Today Novavax weighed in on the FDA's latest stipulations, noting that postmarketing commitments aren't unusual and are in place for many approved drugs and biologics.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
Paxlovid recipients were at significantly lower risk for all-cause hospitalization than those given molnupiravir.
Twelve more pediatric flu deaths were reported, mostly caused by the H1N1 strain, raising the season's total to 98.
During follow-up, the crude all-cause death rate was 18% in the COVID-19 group and 9% among controls.
Relative to 2020 respondents, 2022 participants had less confidence in the CDC, NIH, and local public health departments and more confidence in the federal government, FitBit, and genetic-testing companies.
Chronic conditions and COVID-19 symptoms during infection were risk factors for persistent symptoms, whereas hybrid immunity was protective.
In participants with long COVID, greater lung perfusion correlated with increased chronic fatigue severity.
The number of sudden cardiac arrests and sudden cardiac deaths before and during the pandemic wasn't significantly different.
The overall protection against long COVID from vaccination is likely even higher, because these estimates don't account for infections prevented by vaccines, the authors say.
Only 11% of survivors resumed full-time work by 6 months, while 12% went back to part-time work.
Hydroxychloroquine use was evenly distributed across the United States, but outpatient use of ivermectin was significantly higher in southern states.
